{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:50:52Z","timestamp":1783075852192,"version":"3.54.6"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1124\/mol.119.117143","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:15:29Z","timestamp":1566260129000},"page":"515-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channel"],"prefix":"10.1016","volume":"96","author":[{"given":"Yu-Sheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumel","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria","family":"Lew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onofrio","family":"Laselva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Ip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Wellhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Gonska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo J.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Bear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.119.117143_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41525-017-0015-6","article-title":"Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia","volume":"2","author":"Ahmadi","year":"2017","journal-title":"NPJ Genom Med"},{"key":"10.1124\/mol.119.117143_bib2","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.37963","article-title":"SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion","volume":"7","author":"Ahmadi","year":"2018","journal-title":"eLife"},{"key":"10.1124\/mol.119.117143_bib3","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/ppul.23553","article-title":"Individualized medicine using intestinal responses to CFTR potentiators and correctors","volume":"51","author":"Beekman","year":"2016","journal-title":"Pediatr Pulmonol"},{"issue":"13","key":"10.1124\/mol.119.117143_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99385","article-title":"Brushed nasal epithelial cells are a surrogate for bronchial epithelial CFTR studies","volume":"3","author":"Brewington","year":"2018","journal-title":"JCI Insight"},{"key":"10.1124\/mol.119.117143_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/hum.2017.201","article-title":"Transducing airway basal cells with a helper-dependent adenoviral vector for lung gene therapy","volume":"29","author":"Cao","year":"2018","journal-title":"Hum Gene Ther"},{"key":"10.1124\/mol.119.117143_bib6","doi-asserted-by":"crossref","first-page":"15034","DOI":"10.1038\/mtm.2015.34","article-title":"Testing gene therapy vectors in human primary nasal epithelial cultures","volume":"2","author":"Cao","year":"2015","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1124\/mol.119.117143_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/0194599816640219","article-title":"A low-cost method of ciliary beat frequency measurement using iPhone and MATLAB: rabbit study","volume":"155","author":"Chen","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1124\/mol.119.117143_bib8","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1074\/jbc.M116.762633","article-title":"Attenuation of phosphorylation-dependent activation of cystic fibrosis transmembrane conductance regulator (CFTR) by disease-causing mutations at the transmission interface","volume":"292","author":"Chin","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.117143_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/23808993.2016.1175299","article-title":"Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutation","volume":"1","author":"Cholon","year":"2016","journal-title":"Expert Rev Precis Med Drug Dev"},{"key":"10.1124\/mol.119.117143_bib10","doi-asserted-by":"crossref","first-page":"C1173","DOI":"10.1152\/ajpcell.00384.2011","article-title":"Development of primary human nasal epithelial cell cultures for the study of cystic fibrosis pathophysiology","volume":"303","author":"de Courcey","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/mol.119.117143_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad8278","article-title":"Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis","volume":"8","author":"Dekkers","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1124\/mol.119.117143_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0954-6111(08)80058-3","article-title":"Culture and comparison of human bronchial and nasal epithelial cells in vitro","volume":"84","author":"Devalia","year":"1990","journal-title":"Respir Med"},{"key":"10.1124\/mol.119.117143_bib13","doi-asserted-by":"crossref","first-page":"36639","DOI":"10.1074\/jbc.M112.393637","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner","volume":"287","author":"Eckford","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.117143_bib14","first-page":"L917","article-title":"An electrogenic amino acid transporter in the apical membrane of cultured human bronchial epithelial cells","volume":"275","author":"Galietta","year":"1998","journal-title":"Am J Physiol"},{"issue":"Suppl 62","key":"10.1124\/mol.119.117143_bib15","article-title":"Effects of lumacaftor-ivacaftor therapy on CFTR function in Phe508del homozygous patients with cystic fibrosis","volume":"52","author":"Gr\u00e4ber","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1124\/mol.119.117143_bib16","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1183\/09031936.00103907","article-title":"Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients","volume":"31","author":"Grasemann","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1124\/mol.119.117143_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1183\/09031936.99.13111499","article-title":"Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome","volume":"13","author":"Grasemann","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1124\/mol.119.117143_bib18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1183\/09031936.04.00086104","article-title":"Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study","volume":"25","author":"Grasemann","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1124\/mol.119.117143_bib19","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1164\/ajrccm.162.6.2003106","article-title":"Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene","volume":"162","author":"Grasemann","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/mol.119.117143_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jpeds.2013.02.042","article-title":"Arginine metabolism in patients with cystic fibrosis","volume":"163","author":"Grasemann","year":"2013","journal-title":"J Pediatr"},{"key":"10.1124\/mol.119.117143_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2174\/138161212799315911","article-title":"Nitric oxide and L-arginine deficiency in cystic fibrosis","volume":"18","author":"Grasemann","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1124\/mol.119.117143_bib22","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1164\/rccm.200502-253OC","article-title":"Increased arginase activity in cystic fibrosis airways","volume":"172","author":"Grasemann","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/mol.119.117143_bib23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jcf.2012.12.008","article-title":"A randomized controlled trial of inhaled L-arginine in patients with cystic fibrosis","volume":"12","author":"Grasemann","year":"2013","journal-title":"J Cyst Fibros"},{"key":"10.1124\/mol.119.117143_bib24","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1152\/japplphysiol.00167.2014","article-title":"Lung arginase expression and activity is increased in cystic fibrosis mouse models","volume":"117","author":"Jaecklin","year":"2014","journal-title":"J Appl Physiol (1985)"},{"key":"10.1124\/mol.119.117143_bib25","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1073\/pnas.1215982110","article-title":"Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle","volume":"110","author":"Jih","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.119.117143_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3121\/cmr.2016.1320","article-title":"Dietary nitrate acutely and markedly increased exhaled nitric oxide in a cystic fibrosis case","volume":"14","author":"Kerley","year":"2016","journal-title":"Clin Med Res"},{"key":"10.1124\/mol.119.117143_bib27","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fphar.2018.00719","article-title":"Molecular mechanism of action of trimethylangelicin derivatives as CFTR modulators","volume":"9","author":"Laselva","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1124\/mol.119.117143_bib28","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1124\/mol.118.111799","article-title":"Correctors of the major cystic fibrosis mutant interact through membrane-spanning domains","volume":"93","author":"Laselva","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.119.117143_bib29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.gastro.2003.10.049","article-title":"The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon","volume":"126","author":"Mall","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1124\/mol.119.117143_bib30","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0092-8674(00)81724-9","article-title":"Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease","volume":"95","author":"Matsui","year":"1998","journal-title":"Cell"},{"key":"10.1124\/mol.119.117143_bib31","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1177\/1087057115605834","article-title":"Facilitating structure-function studies of CFTR modulator sites with efficiencies in mutagenesis and functional screening","volume":"20","author":"Molinski","year":"2015","journal-title":"J Biomol Screen"},{"key":"10.1124\/mol.119.117143_bib32","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/prot.25496","article-title":"Comprehensive mapping of cystic fibrosis mutations to CFTR protein identifies mutation clusters and molecular docking predicts corrector binding site","volume":"86","author":"Molinski","year":"2018","journal-title":"Proteins"},{"issue":"80","key":"10.1124\/mol.119.117143_bib33","doi-asserted-by":"crossref","DOI":"10.3791\/50646-v","article-title":"Culturing of human nasal epithelial cells at the air liquid interface","author":"M\u00fcller","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1124\/mol.119.117143_bib34","doi-asserted-by":"crossref","first-page":"15370","DOI":"10.1073\/pnas.0706974104","article-title":"Processing and function of CFTR-DeltaF508 are species-dependent","volume":"104","author":"Ostedgaard","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.119.117143_bib35","doi-asserted-by":"crossref","first-page":"7375","DOI":"10.1038\/s41598-017-07504-1","article-title":"Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators","volume":"7","author":"Pranke","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/mol.119.117143_bib36","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0954-6111(99)90158-0","article-title":"Effect of inhaled nitric oxide on pulmonary function in cystic fibrosis","volume":"93","author":"Ratjen","year":"1999","journal-title":"Respir Med"},{"key":"10.1124\/mol.119.117143_bib37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-2600(17)30215-1","article-title":"Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial","volume":"5","author":"Ratjen","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1124\/mol.119.117143_bib38","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/thx.2011.159491","article-title":"VX-770, a CFTR potentiator, may have a potential clinical benefit in a subgroup of people with cystic fibrosis","volume":"66","author":"Shah","year":"2011","journal-title":"Thorax"},{"key":"10.1124\/mol.119.117143_bib39","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1164\/ajrccm.165.7.2105032","article-title":"Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis","volume":"165","author":"Snyder","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/mol.119.117143_bib40","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s40425-017-0308-4","article-title":"Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment","volume":"5","author":"Steggerda","year":"2017","journal-title":"J Immunother Cancer"},{"key":"10.1124\/mol.119.117143_bib41","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1113\/jphysiol.2004.068171","article-title":"Regulation of human airway ciliary beat frequency by intracellular pH","volume":"560","author":"Sutto","year":"2004","journal-title":"J Physiol"},{"key":"10.1124\/mol.119.117143_bib42","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jcf.2014.10.006","article-title":"Pharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung disease","volume":"14","author":"Taylor-Cousar","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1124\/mol.119.117143_bib43","doi-asserted-by":"crossref","first-page":"25103","DOI":"10.1016\/S0021-9258(19)49254-5","article-title":"Protein kinase CK2, cystic fibrosis transmembrane conductance regulator, and the deltaF508 mutation: F508 deletion disrupts a kinase-binding site","volume":"283","author":"Treharne","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.119.117143_bib44","first-page":"A5806","article-title":"The in vitro and ex vivo efficacy of novel arginase inhibitors for the treatment of allergic asthma","volume":"197","author":"van den Berg","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/mol.119.117143_bib45","doi-asserted-by":"crossref","first-page":"18825","DOI":"10.1073\/pnas.0904709106","article-title":"Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770","volume":"106","author":"Van Goor","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.119.117143_bib46","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.119.117143_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcf.2013.06.008","article-title":"Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function","volume":"13","author":"Van Goor","year":"2014","journal-title":"J Cyst Fibros"},{"key":"10.1124\/mol.119.117143_bib48","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.119.117143_bib49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.abb.2011.04.003","article-title":"Regulation of ciliary motility: conserved protein kinases and phosphatases are targeted and anchored in the ciliary axoneme","volume":"510","author":"Wirschell","year":"2011","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/mol.119.117143_bib50","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jcf.2011.12.005","article-title":"Ivacaftor potentiation of multiple CFTR channels with gating mutations","volume":"11","author":"Yu","year":"2012","journal-title":"J Cyst Fibros"},{"key":"10.1124\/mol.119.117143_bib51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1358\/dot.2016.52.4.2467205","article-title":"Lumacaftor\/ivacaftor combination for cystic fibrosis patients homozygous for Phe508del-CFTR","volume":"52","author":"Zhang","year":"2016","journal-title":"Drugs Today (Barc)"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24009556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24009556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.119.117143","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:31:02Z","timestamp":1739961062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24009556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0026895X24009556"],"URL":"https:\/\/doi.org\/10.1124\/mol.119.117143","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channel","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.119.117143","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}